Secukinumab for Giant Cell Arteritis.
- DOI
- 10.1056/evidoa2600112
- Published
- 2026 Jul
- Container
- NEJM evidence
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1056/evidoa2600112,
title = {Secukinumab for Giant Cell Arteritis.},
author = {Stone JH and Venhoff N and Buttgereit F and Dejaco C and Schmidt WA and Spiera R and Blanco R and Rubbert-Roth A and Von Frenckell C and Blockmans D and Terrier B and Tracey G and Hauge EM and Keyport MP and Ng J and Hiremath R and Fu R and Cho G and Bacher G and Thiel J and Mendelson MH},
year = {2026},
journal = {NEJM evidence},
doi = {10.1056/evidoa2600112},
url = {https://doi.org/10.1056/evidoa2600112}
}RIS
TY - JOUR TI - Secukinumab for Giant Cell Arteritis. AU - Stone JH AU - Venhoff N AU - Buttgereit F AU - Dejaco C AU - Schmidt WA AU - Spiera R AU - Blanco R AU - Rubbert-Roth A AU - Von Frenckell C AU - Blockmans D AU - Terrier B AU - Tracey G AU - Hauge EM AU - Keyport MP AU - Ng J AU - Hiremath R AU - Fu R AU - Cho G AU - Bacher G AU - Thiel J AU - Mendelson MH PY - 2026 JO - NEJM evidence DO - 10.1056/evidoa2600112 UR - https://doi.org/10.1056/evidoa2600112 ER -
APA
JH, S., N, V., F, B., C, D., WA, S., R, S., R, B., A, R., C, V. F., D, B., B, T., G, T., EM, H., MP, K., J, N., R, H., R, F., G, C., G, B., J, T., & MH, M. (2026). Secukinumab for Giant Cell Arteritis.. NEJM evidence. https://doi.org/10.1056/evidoa2600112
Source records
- pubmed · retrieved 2026-09-25T11:40:09.591Z